Browsing Tag
proteomics
4 posts
What Alamar Biosciences’ (NASDAQ: ALMR) IPO pop says about the next phase of proteomics investing
Alamar Biosciences surged after its upsized IPO. Read what the debut means for proteomics, public markets, and life science tools investors.
Can Illumina’s SomaLogic takeover finally make multiomics scalable at pharma speed?
Illumina has acquired SomaLogic to deepen its proteomics and multiomics capabilities. Find out what this means for genomics, pharma, and platform rivals.
How the Nautilus Biotechnology and Michael J. Fox Foundation alliance signals a shift in Parkinson’s biomarker strategy (NASDAQ: NAUT)
Find out how Nautilus Biotechnology’s Parkinson’s collaboration signals a strategic shift in biomarker platforms and what it means for investors and drug developers.
Quantum-Si secures $50m in registered direct offering to expand single-molecule protein sequencing platform
Quantum-Si Incorporated secures $50 million through a registered direct offering of common stock, bolstering its single-molecule proteomics platform.